Correction: Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older

Pharmacoecon Open. 2024 Sep;8(5):785. doi: 10.1007/s41669-024-00502-w.

Authors

Sydney George¹, Justin Carrico², Katherine A Hicks², Dessi Loukov³, Cheryl Ng⁴, Jessica Regan³, Nikolaos Giannelos⁵

Affiliations

¹ GSK, Mississauga, ON, Canada. [email protected].
² RTI Health Solutions, Research Triangle Park, NC, USA.
³ GSK, Mississauga, ON, Canada.
⁴ GSK, Singapore, Singapore.
⁵ GSK, Wavre, Belgium.

No abstract available

Publication types

Published Erratum